Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic Nomogram for Advanced Hepatocellular Carcinoma Treated with FOLFOX 4
Shukui Qin, Xinji Zhang, Wei Guo, et al.
PubMed (2017) Vol. 18, Iss. 5, pp. 1225-1232
Closed Access | Times Cited: 10

Showing 10 citing articles:

A new prognostic model for predicting overall survival and progression-free survival in unresectable hepatocellular carcinoma treated with the FOLFOX-HAIC regimen based on patient clinical characteristics and blood biomarkers
Qiuyao Zeng, Zehong Zhou, Ji Zhang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Risk Factors and Predictive Analysis of Acute Severe Abdominal Pain After Hepatic Artery Infusion Chemotherapy in Patients with Hepatocellular Carcinoma
Jinpeng Li, Congcong Shi, Jiao Chen, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 289-299
Open Access
Napabucasin Reduces Cancer Stem Cell Characteristics in Hepatocellular Carcinoma
Ya Li, Qiuju Han, Huajun Zhao, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 19
Upregulated UCA1 contributes to oxaliplatin resistance of hepatocellular carcinoma through inhibition of miR‐138‐5p and activation of AKT/mTOR signaling pathway
Guolin Huang, Li Li, Chaoyong Liang, et al.
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 13
Prognostic models for outcome prediction in patients with advanced hepatocellular carcinoma treated by systemic therapy: a systematic review and critical appraisal
Li Li, Xiaomi Li, Wendong Li, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 10
The Performance of a Survival Nomogram and Albumin–Bilirubin Grade as Prognostic Tools in Advanced Hepatocellular Carcinoma Treated with FOLFOX4
Jirapat Wonglhow, Patrapim Sunpaweravong, Chirawadee Sathitruangsak, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 403-403
Open Access | Times Cited: 1
The In-Vitro Antitumor Effects of AST-3424 Monotherapy and Combination Therapy With Oxaliplatin or 5-Fluorouracil in Primary Liver Cancer
Yu Zhang, Shukui Qin, Jiaojiao Chao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
<p>Cytotoxic Chemotherapy as an Alternative for Systemic Treatment of Advanced Hepatocellular Carcinoma in Developing Countries</p>
Khaled Abouelezz, Dipen Khanapara, Gaber El‐Saber Batiha, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 12239-12248
Open Access | Times Cited: 6
LABS score– a prognostic tool for FOLFOX4-treated advanced hepatocellular carcinoma and real-world efficacy: a single-center retrospective study
Jirapat Wonglhow, Patrapim Sunpaweravong, Chirawadee Sathitruangsak, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Hepatic Artery Infusion Chemotherapy Sequential Hepatic Artery Embolization Combined with Operation in the Treatment of Recurrent Massive Hepatocellular Carcinoma Achieved Pathological Complete Response: A Case Report
Junjie Chen, Xiwen Liao, Yining Wu, et al.
Pharmacogenomics and Personalized Medicine (2023) Vol. Volume 16, pp. 949-958
Open Access
Page 1

Scroll to top